§33-54-1. Short Title

This article shall be known and cited as the Requiring Accountable Pharmaceutical Transparency, Oversight, and Reporting Act.

§33-54-2. Definitions

For the purpose of this article: “Auditor” means the State Auditor of West Virginia, by himself or herself, or by any person appointed, designated, or approved by the State Auditor to perform the service. “Brand-name drug” means a prescription drug approved under 21 USC 355(b) or 42 USC 262. “Drug” or “prescription drug” refers to […]

§33-54-3. Drug Manufacturer Reporting Requirements

(a) Not later than January 15 of each calendar year, a drug manufacturer shall submit a report to the Auditor stating the following information for each brand-name, specialty, and generic drug manufactured by the drug manufacturer and sold in the state directly by the drug manufacturer or a wholesale drug distributor: Provided, That the requirements […]

§33-54-4. Health Benefit Plan Issuer Reporting Requirements

No later than March 1 of each calendar year, each health benefit plan issuer shall submit to the Auditor a report providing the following information for the immediately preceding calendar year: Provided, That nothing in this article should be construed as to requiring a health benefit plan issuer to disclose confidential health information protected by […]

§33-54-5. Auditor S Searchable Pharmaceutical Transparency Website Created

(a) By July 1, 2021, the Auditor shall create a searchable pharmaceutical price transparency website, containing the information specified in §33-54-3 and §33-54-4 of this code, available to the public at no cost, and presented in a consumer-friendly, searchable format. (b) Effective July 1, 2021, the Auditor shall update the information displayed on the searchable […]